Regulatory Disclosure Summary:
Product Development Milestone:
- Product Name: PFH-VAP
- Commercial/Brand Name: VIT A+
- Nature of Product: Stable formulation of Vitamin A Palmitate
- Application/Intended Use: Developed for large-scale food fortification applications
- Development Nature: Successful completion of commercial-scale process validation
- Parties Involved: Particles for Humanity and Hexagon Nutrition Limited
- Key Milestone: Successful completion of commercial-scale process validation of PFH-VAP
Strategic Implications:
The successful completion represents an important milestone in the development and scale-up of PFH-VAP and demonstrates the feasibility of its manufacturing process at commercial scale. The product is intended to support large-scale food fortification applications, with the objective of enabling effective and stable delivery of Vitamin A through fortified food products.
Commercialization Plan:
The product is proposed to be commercially marketed under the brand name "VIT A+" in international markets. The Company will continue to undertake the necessary steps towards commercialization of VIT A+, subject to applicable regulatory and commercial requirements.
Compliance Details:
- Regulatory Reference: SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulation 30)
- Disclosure Date: 29th September 2026
- Company Secretary: Vedanti Vartak (ICSI Membership No.: A41580)
Company Locations:
- Nashik Plant: Plot No. 92 & Plot No. 447, Unandanagar, Lakhamapur, Dindori, Nashik - 422 202, Maharashtra, India
- Chennai Plant: Plot No. B11, Phase - 1 MEPZ-SEZ, Tambaram, Chennai - 600 045, Tamil Nadu, India
Sections Not Applicable:
- KMP / Board / Auditor Changes: Not Specified
- Dividend Declaration / Revision / Non-Declaration: Not Specified
- Board Meeting Outcomes: Not Specified
- Financial Results: Not Specified
- Auditor's Report: Not Specified
- Disinvestment / Strategic Actions: Not Specified
- Media Release / Investor Communication: Not Specified